Evidence map›Paper›PMID 38675164›Full record

ArticlePharmaceutics2024

Pharmacogenomic Studies of Antiviral Drug Favipiravir.

Victoria V Shumyantseva, Tatiana V Bulko, Alexey A Chistov, Ekaterina F Kolesanova, Lyubov E Agafonova

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Victoria V ShumyantsevaInstitute of Biomedical Chemistry, Pogodinskaya Street, 10, Build 8, Moscow 119121, Russia.ORCID 0000-0002-1509-7218
Tatiana V BulkoInstitute of Biomedical Chemistry, Pogodinskaya Street, 10, Build 8, Moscow 119121, Russia.
Alexey A ChistovInstitute of Biomedical Chemistry, Pogodinskaya Street, 10, Build 8, Moscow 119121, Russia.
Ekaterina F KolesanovaInstitute of Biomedical Chemistry, Pogodinskaya Street, 10, Build 8, Moscow 119121, Russia.
Lyubov E AgafonovaInstitute of Biomedical Chemistry, Pogodinskaya Street, 10, Build 8, Moscow 119121, Russia.
Institute of Biomedical Chemistry · RUPirogov Russian National Research Medical University · RU

Funding

The Ministry of Education and Science of the Russian Federation "Digital biodesign and Personalized Healthcare" No. 075-15-2022-305
6 · The paper itself

Abstract

In this work, we conducted a study of the interaction between DNA and favipiravir (FAV). This chemotherapeutic compound is an antiviral drug for the treatment of COVID-19 and other infections caused by RNA viruses. This paper examines the electroanalytical characteristics of FAV. The determined concentrations correspond to therapeutically significant ones in the range of 50-500 µM (R

Indexed as

DNAdrug/DNA interactionelectrochemistryfavipiravirmodified electrodes

Identifiers

PMID38675164
PMCPMC11053860
OpenAlexW4394579396

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.